| DC Field | Value | Language |
|---|
| dc.contributor.author | Zemskova, V. A. | - |
| dc.contributor.author | Trubchanina, Yu. A. | - |
| dc.contributor.author | Berezhnova, T. A. | - |
| dc.contributor.author | Zemskov, A. M. | - |
| dc.contributor.author | Borisov, V. A. | - |
| dc.date.accessioned | 2024-03-18T14:21:14Z | - |
| dc.date.available | 2024-03-18T14:21:14Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Pharmacological body-wide and immunotropic effects of galavit in the treatment of patients with purulent-inflammatory diseases of various origins and allergization / V.A. Zemskova, Trubchanina Yu.A., T.A. Berezhnova [et al.] // Research Results in Pharmacology. - 2023. - Vol.9, №3.-P. 41-49. - Doi: 10.18413/rrpharmacology.9.10044. - Refer.: p. 48. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/61380 | - |
| dc.description.abstract | The aim of the study was to specify pharmacological (body-wide) and specific (immunotropic) effects of the immunomodulator galavit additionally prescribed in the context of basic treatment for patients with deep pyoderma, chronic pyelonephritis, adnexitis, purulent infection of soft tissues, complicated by atopic dermatitis | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | atopic dermatitis | ru |
| dc.subject | galavit | ru |
| dc.subject | purulent-inflammatory diseases | ru |
| dc.subject | immuno-metabolic disorders | ru |
| dc.subject | clinical and laboratory efficiency | ru |
| dc.title | Pharmacological body-wide and immunotropic effects of galavit in the treatment of patients with purulent-inflammatory diseases of various origins and allergization | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 9, № 3
|
